| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JAMCOLLSURG.2007.03.020 |
| P698 | PubMed publication ID | 17660072 |
| P2093 | author name string | William C Chapman | |
| Fred A Weaver | |||
| Neil Singla | |||
| Aileen Murphy | |||
| James W McNeil | |||
| Kenneth L Renkens | |||
| Thomas C Reynolds | |||
| Yuri Genyk | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 256-265 | |
| P577 | publication date | 2007-06-27 | |
| P1433 | published in | Journal of the American College of Surgeons | Q15723630 |
| P1476 | title | A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis | |
| P478 | volume | 205 |
| Q50144854 | A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin. |
| Q82459950 | A Multicenter Pilot Study to Estimate the Prevalence of Bovine and Human Coagulation Antibodies in the General US Population |
| Q42637936 | A heuristic approach and heretic view on the technical issues and pitfalls in the management of penetrating abdominal injuries |
| Q30430562 | A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs |
| Q58695090 | A systematic review on the use of topical hemostats in trauma and emergency surgery |
| Q37465624 | Advances in bioadhesives, tissue sealants, and hemostatic agents |
| Q37837684 | Advances in the surgical management of chronic sinusitis and nasal polyps |
| Q38107909 | An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis |
| Q28481282 | Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins |
| Q40167905 | Arabinogalactan:β-glucan as novel biodegradable carriers for recombinant human thrombin |
| Q38177551 | Armentarium of topical hemostatic products in cardiovascular surgery: an update |
| Q37492672 | Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety |
| Q37586947 | Clinical use of topical thrombin as a surgical hemostat |
| Q36887203 | Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model |
| Q50948250 | Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures. |
| Q50848048 | Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients. |
| Q50033538 | Do not underestimate the femoral pseudoaneurysm |
| Q36089539 | Efficacy of a topical bovine-derived thrombin solution as a hemostatic agent in a rodent model of hepatic injury |
| Q49247169 | Hemostasis and nanotechnology |
| Q92368527 | Hemostatic Thrombin-Gelatin Matrix-Related Intracranial Cyst Formation |
| Q35620486 | Hemostatic effect and distribution of new rhThrombin formulations in rats |
| Q37230558 | Improved bleeding scores using Gelfoam(®) Powder with incremental concentrations of bovine thrombin in a swine liver lesion model |
| Q38095688 | Medical management of paediatric burn injuries: best practice part 2. |
| Q24197525 | Methods to decrease blood loss during liver resection: a network meta-analysis |
| Q38994915 | Methods to decrease blood loss during liver resection: a network meta-analysis. |
| Q36111366 | Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma |
| Q37111243 | Newer hemostatic agents used in the practice of dermatologic surgery |
| Q38056215 | Optimizing hemostatic practices: matching the appropriate hemostat to the clinical situation |
| Q38868935 | Platelet-rich plasma stimulated by pulse electric fields: Platelet activation, procoagulant markers, growth factor release and cell proliferation. |
| Q37853216 | Proteases as therapeutics |
| Q83179520 | Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model |
| Q34728463 | Protein therapeutics: a summary and pharmacological classification |
| Q34246054 | Results of a new human recombinant thrombin for the treatment of arterial pseudoaneurysm |
| Q36512498 | Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature |
| Q46070437 | Safety and efficacy of thrombin-JMI: a multidisciplinary expert group consensus |
| Q45723620 | Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials |
| Q42006534 | Safety of topical thrombins: the ongoing debate |
| Q27340130 | Self-propelled particles that transport cargo through flowing blood and halt hemorrhage |
| Q37313598 | Skin and Skin Structure Infections, And Control of Hemostasis during Surgery. |
| Q24622347 | Soft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gels |
| Q30451543 | State-of-the-art review: Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox |
| Q37979181 | Thrombin use in surgery: an evidence-based review of its clinical use. |
| Q93157519 | Topical biomaterials to prevent post-tonsillectomy hemorrhage |
| Q37267995 | Topical hemostatic agents in surgery: a surgeon's perspective |
| Q37951170 | Topical hemostatic agents in surgical practice |
| Q37452699 | Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding |
| Q37532512 | Topical thrombins: benefits and risks |
| Q26861415 | Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents |
Search more.